Last update 21 Nov 2024

Irpagratinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Mechanism
FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC28H32F2N6O5
InChIKeyPGRHEHZIRYNZDV-FUHWJXTLSA-N
CAS Registry2230974-62-4

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 2
CN
30 Dec 2021
Advanced Hepatocellular CarcinomaPhase 1
CN
26 Feb 2020
Advanced Malignant Solid NeoplasmPhase 1
CN
26 Feb 2020
FGFR4 positive Solid TumorsIND Approval
CN
19 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
Advanced Hepatocellular Carcinoma
Second line
FGF19 overexpression
109
(fjzrrgtgbb) = most common (>20%) were alanine aminotransferase (ALT) increased (70.6%), diarrhea (67.9%), aspartate aminotransferase (AST) increased (56.9%), hyperphosphataemia (37.6%), bilirubin increased (35.8%), total bile acids increased (21.1%) and alkaline phosphatase increased (20.2%). Majority of TRAEs were Gr 1-2 and reversible/manageable. zfvyfnjdrv (odhnhqqipq )
Positive
16 Sep 2024
Phase 1
75
(fvxpsjzpre) = gdrrxuzcja yrqlrlfqyd (bloljhihnf )
Positive
23 Oct 2023
ABSK-011 400 mg QD
(qkyucdrbwk) = jfyeooefmj ghrbntnnqx (rbrxfkjvcc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free